BTQ Technologies shifts focus to quantum-secure settlement with QSSN. Learn about its strategy, risks, and outlook.
IREN stock dropped despite strong AI growth and platform progress. Learn about its revenue shifts, debt strategy, and future ...
Linking nanopores with nanofluidic chips can slow molecules, cut noise, scale measurements, and enable early disease ...
The timing looks painful, but the fundamentals tell a more complicated story about why long-term investors are still paying attention.
When disease begins forming inside the human body, something subtle happens long before symptoms appear. Individual molecules ...
Activation of certain memory B cells may be driving systemic lupus erythematosus incidence in individuals who had ...
Left-shifting DFT, scalable tests from manufacturing to the field, enabling system-level tests for in-field debug.
Summary • VolitionRX Limited (VNRX) rose 12.8% pre-market, increasing from $0.2421 to $0.2730, driven by positive investor sentiment despite no clear catalyst.• Recent advancements in liquid biopsy ...
PLAMseq utilizes a rapid biotinylation enzyme called TurboID, which tags nearby proteins, enabling the genomic loci and ...
Whole Genome Amplification (WGA) offers vast opportunities in personalized medicine, cancer research, and reproductive health ...
Risk management news: the latest regulation and compliance updates and advice from the Wall Street Journal.
Background Metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma (MASH-HCC) has been reported to be less responsive to immune checkpoint inhibitors, which may be associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results